SA
Sign upLog In

Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA)

EBITDA

$2.59B

TTM · Period ending: · USD

TEVA logo

TEVA EBITDA

Latest reported$2.59B
TEVA TTM EBITDA ($48.20M → $2.59B)
High-resolution chart · PNG

TEVA ebitda history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Teva Pharmaceutical Industries Limited American Depositary Shares EBITDA — Trailing twelve months (TTM) (USD)
Period endingEBITDA (USD)
416,127,000
422,736,000
396,895,000
282,557,000
273,337,000
221,078,000
206,415,000
190,700,000
163,700,000
143,400,000
138,300,000
-558,800,000
-310,300,000
-60,500,000
173,800,000
278,200,000
228,100,000
207,600,000
129,300,000
316,500,000
245,200,000
151,800,000
115,200,000
154,400,000
132,600,000
122,700,000
106,700,000
144,400,000
128,100,000
106,200,000
87,900,000
151,800,000
117,600,000
85,600,000
60,100,000
86,600,000
72,300,000
57,100,000
51,500,000
95,000,000
78,900,000
70,700,000
49,100,000
46,300,000
47,500,000
46,700,000
49,200,000
78,600,000
61,400,000
42,700,000
24,500,000
175,200,000
155,000,000
19,500,000
4,400,000
10,800,000
19,300,000
48,200,000
36,100,000
24,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.